You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 24, 2024

Details for New Drug Application (NDA): 010402

✉ Email this page to a colleague

« Back to Dashboard

NDA 010402 describes PREMARIN, which is a drug marketed by Wyeth Pharms and is included in three NDAs. It is available from two suppliers. Additional details are available on the PREMARIN profile page.

The generic ingredient in PREMARIN is estrogens, conjugated. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the estrogens, conjugated profile page.
Summary for 010402
Applicant:Wyeth Pharms
Ingredient:estrogens, conjugated
Formulation / Manufacturing:see details
Pharmacology for NDA: 010402
Mechanism of ActionEstrogen Receptor Agonists
Suppliers and Packaging for NDA: 010402
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREMARIN estrogens, conjugated INJECTABLE;INJECTION 010402 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-0749 0046-0749-05 1 VIAL in 1 CARTON (0046-0749-05) / 5 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength25MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.